Showing results (51-60 of 2,405) with videos related to

Sort By:
Pageof 241
Journal of Medical Economics|June 2, 2020
Estimating health state utilities associated with a rare disease: familial chylomicronemia syndrome (FCS)Louis S Matza, Glenn A Phillips, Timothy A Howell, et al.
Journal of Medical Economics|May 14, 2020
The fiscal consequences of public health investments in disease-modifying therapies for the treatment of multiple sclerosis in SwedenNikolaos Kotsopoulos, Mark P Connolly, Thibaut Dort, et al.
Journal of Medical Economics|September 8, 2021
Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United StatesSneha S Jain, Sophia S Li, Jipan Xie, et al.
Journal of Medical Economics|August 25, 2025
Cost-effectiveness of insulin icodec for the treatment of type 2 diabetes in CanadaDavid A Garcia, Godfrey Mau, Sumeet Singh, et al.
Journal of Medical Economics|May 5, 2020
Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United StatesJun Su, Lauren C Bylsma, Xiaohui Jiang, et al.
Journal of Medical Economics|May 5, 2020
Budget impact analysis for dapagliflozin in type 2 diabetes in EgyptGihan Hamdy Elsisi, Mohammed Moustapha Anwar, Mohamed Khattab, et al.
Journal of Medical Economics|April 10, 2020
Budget impact analysis of long acting injection for schizophrenia in JapanMami Kasahara-Kiritani, Amish Chaturvedi, Ataru Inagaki, et al.
Journal of Medical Economics|August 6, 2021
Cost of hemophilia A in Turkey: an economic disease burden analysisSimten Malhan, Ergün Öksüz, Bülent Antmen, et al.
Pageof 241